Share

Manufacturer

Illumina

NgeneBio

Application

Detection BRCA gene in breast cancer

Products of interest

Batch Convert Unplayable Videos

Zymot ICSI

Next-Generation Sequencing System – NextSeq 2000

Detection mutation of BRCA cancer gene

Breast cancer is the most common cancer in women. About 5-10% of breast cancer is caused by genetic factors (inherited genetic changes called mutations). Mutations in the BRCA1 and BRCA2 genes are the leading risk factors for breast cancer.

Biomedic's solution

Using BRCA gene mutation kits to detect breast cancer types, Biomedic provides test kits:

  • With CE-IVD certification for clinical diagnosis
  • The kit is researched on the Asian human genome – similar to the Vietnamese genome
  • High accuracy and specificity for breast cancer gene detection

Product

BRCAaccuTest™ & BRCAaccuTest™PLUS

BRCAaccuTest™ & BRCAaccuTest™PLUS is a regent for producing libraries for
analyzing the BRCA ½ genes using the NGS (next-generation sequencing) method,
which analyzes genomic DNA derived from blood or FFPE tissues.

Next Generation Sequencing System – MiSeq

Model: MiSeq
Manufacturer: Illumina/USA
– The MiSeq System combines cluster generation, amplification, sequencing and data analysis on a single system
– The system is most widely used, with next-generation sequencing technology –  Sequencing by Synthesis – SBS

Share

Manufacturer

Illumina

NgeneBio

Application

Detection BRCA gene in breast cancer

Products of interest

Batch Convert Unplayable Videos

Zymot ICSI

Next-Generation Sequencing System – NextSeq 2000